PURPOSE: To investigate the predictors of incidence and duration of xerostomia (XT) based
on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole …

Purpose: Investigation of the influence of radiation dose to salivary glands on xerostomia in
patients with head and neck cancers. Methods: From October 2002 to December 2011, 548 …

Purpose: To assess long-term xerostomia in patients receiving parotid-sparing radiation
therapy (RT) for head-and-neck cancer, and to find the patient and therapy-related factors …

BACKGROUND AND PURPOSE: To investigate the association between the mean salivary
gland and oral cavity dose, with patient-rated moderate and severe xerostomia and sticky …

PURPOSE: The severe reduction of salivary function (xerostomia) is a common complication
after radiation therapy for head-and-neck cancer. Consequently, guidelines to ensure …

Radiotherapy (RT) for head and neck cancers causes permanent salivary gland dysfunction
(SGD) and xerostomia. We have previously demonstrated the effectiveness of parotid …

Background: Parotid-sparing intensity-modulated radiotherapy (IMRT) effectively reduces
xerostomia in head-and-neck cancer (HNC). Changes in the salivary output at 1 year were …

Background/Aim: Optimal planning of radiotherapy for head-and-neck cancers should
consider the risk of xerostomia. This study investigated the prognostic value of dosevolume …

A dry mouth or xerostomia is one of the most common complications during and after
radiotherapy for head and neck cancer, because irreparable damage is caused to the …

Objectives: In a prospective clinical study, we tested the hypothesis that sparing the parotid
glands may result in significant objective and subjective improvement of xerostomia in …